Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Wistar Institut Of Anatomy And Biology manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This single matter is assigned to 1 distinct examiner, reflecting a focused prosecution environment. This focused interaction suggests that the company's current intellectual property efforts are channeled through a single administrative path within the patent office, which may allow for a consistent prosecution strategy.
The activity is situated within 1 distinct art unit, which aligns with the specialized nature of the biotechnology field. Andrea Staffel Olson is the busiest examiner for the portfolio, responsible for the 1 busiest examiner pending office action. With only one action pending in total, this examiner manages the entire current active workload for the institute. This structure provides a singular point of contact for the institute's biotechnological patenting efforts, requiring the practitioner to focus their advocacy on the specific preferences and tendencies of this one examiner, as they have complete oversight of the active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ANDREA STEFFEL | 1 | 62.4% | -11.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734491 | METHODS OF TREATING CANCERS OVEREXPRESSING CARM1 WITH EZH2 INHIBITORS AND A PARP INHIBITOR | OLSON, ANDREA STEFFEL | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734491 | METHODS OF TREATING CANCERS OVEREXPRESSING CARM1 WITH EZH2 INHIBITORS AND A PARP INHIBITOR | OLSON, ANDREA STEFFEL | 1693 | §103§112Other | Non-Final OA | — | Pending | Jun 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Wistar Institut Of Anatomy And Biology has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Andrea Steffel Olson has the most, with 1 of The Wistar Institut Of Anatomy And Biology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
